Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|May 2, 2020
- Pharmaceutical Technology-05-02-2020
- Volume 44
- Issue 5
Inline High Shear Mixers
Inline high shear mixers from ROSS are available from 1 through 250 HP to accelerate mixing, emulsification, and homogenization in recirculation and continuous modes.
Inline high shear mixers from ROSS are available from 1 through 250 HP to accelerate mixing, emulsification, and homogenization in recirculation and continuous modes. The mixer can be used anywhere in a plant because of its mobile skid, eliminating the need for multiple mixers separately dedicated to each vessel or product.
The ROSS Model HSM-410 Inline High Shear Mixer (pictured) has the ability to handle applications with viscosities of up to 20,000 cP and a seperate control panel may be mounted to the cart and wired to the mixer motor for complete portability. Additionally, 3A-approved sanitary models are available with tri-clamp inlet/outlet connections and a one-piece stator/chamber cover. Ultra-high shear mixer models are also available.
Articles in this issue
over 6 years ago
Modern Drug Manufacturing Key to COVID-19 Responseover 6 years ago
How Fast Is Too Fast?over 6 years ago
Starting a Career in the Bio/Pharmaceutical Industryover 6 years ago
Can We Teach an Old Drug New Tricks?over 6 years ago
Good Manufacturing Practices: Aseptic and Sterile Processingover 6 years ago
Small-Volume Conversion Kit for Bathless Dissolution Testersover 6 years ago
Pre-Packed Columnsover 6 years ago
Laser-Marked Smart ContainersRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
3
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
4
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
5